Insiders · Profile

Kim Robert Young

Chief Medical Officer at 4D Molecular Therapeutics. Filing since 5 Feb 2024. CIK 0001971608

Company
Date
Role
Action
Shares
Amount
Of holding
5 Feb 2024
Chief Medical Officer
Sold on a plan
24,552
$737.79K
95.9%
1 decision on file.